SRC and neoplasm: Jia et al. demonstrated that LIMK1, which phosphorylates and inactivates CFL, was significantly overexpressed in CC tissues and promoted tumor growth, migration, and invasion via a ROS/Src-dependent pathway involving p-FAK, p-ROCK1/2, and p-CFL1.